Market Research > Browse Research > Life Sciences > Biotechnology > Stem Cell

Stem Cell: market research reports

Stem cells are unique in that they are undifferentiated cells that can differentiate to become virtually any type of cell in the body (totipotent). They therefore represent an ongoing source of the specialized cells that make up the tissues and organs. There is great interest in stem cells because they have potential to replace defective or damaged cells resulting from a variety of disorders and injuries, leading to a range of new regenerative therapies.

Stem cells also have value as a research tool, as their in vitro study would allow scientists to learn more about the function of various organs and the development of particular diseases; stem cells may also eventually permit drug developers to test emerging therapies on diseased cells.

Cells must meet very specific criteria in order to be termed stem cells. They must: produce copies themselves; proliferate at a rapid rate; and display certain proteins on their surface that indicate a capacity to differentiate into other tissues, such as bone and cartilage. A stem cell line is a group of cells that all descend from a single original stem cell. Symmetric division gives rise to two identical daughter cells both endowed with stem cell properties. Asymmetric division produces only one stem cell and a progenitor cell with limited self-renewal potential.

Stem Cell market research reports and industry analysis

Plunkett's Health Care Technologies Overview 2014: A Summary Excerpted from Plunkett's Health Care Industry Almanac 2014 11/12/2013 \| published by: Plunkett Research, Ltd. ... Research Online Link to our 5-minute video overview of this industry Pages: 76 Statistical Tables Provided: 40 Geographic Focus: Global A condensed market research report excerpted from Plunkett’s Health Care Industry Almanac 2014, including forecasts ... \| read more...	$199.99
Plunkett's Health Care Industry Trends & Statistics 2014: A Summary Version of Plunkett's Health Care Industry Almanac 2014 11/12/2013 \| published by: Plunkett Research, Ltd. ... at Plunkett Research Online Link to our 5-minute video overview of this industry Pages: 79 Statistical Tables Provided: 40 Geographic Focus: Global A condensed market research report excerpted from Plunkett’s Health Care Industry Almanac 2014, ... \| read more...	$199.99
Plunkett's Health Care Industry Almanac 2014: Health Care Industry Market Research, Statistics, Trends & Leading Companies 11/12/2013 \| published by: Plunkett Research, Ltd. ... Professional Societies List In-Depth Profiles of hundreds of leading companies Industry Glossary Buyer may register for free access to search and export data at Plunkett Research Online Link to our 5-minute video overview of this ... \| read more...	$349.99
Capitalizing on Opportunities in Cord Blood Industry Growth (2013 Version) 11/1/2013 \| published by: BioInformant Worldwide, L.L.C. ... as of 2005, and now there are 485 worldwide. Cord blood banks now exist within 98 different countries around the world. That is a 21-fold increase (2,100%) in the companies involved in the industry, in ... \| read more...	$3,995.00
Opportunities in Human Embryonic Stem Cell (hESC) Products - Trends and Forecasts to 2017 10/1/2013 \| published by: BioInformant Worldwide, L.L.C. ... to differentiate into any mature cell type. Categorized by stage of life, several broad categories of stem cells exist, including: Embryonic stem cells, derived from blastocysts Post-natal stem cells, derived from newborn tissues Adult stem ... \| read more...	$3,495.00
ADME-Toxicology Testing 10/1/2013 \| published by: Global Industry Analysts ... the US, Canada, Japan, Europe, Asia-Pacific, and Rest of World. Annual estimates and forecasts are provided for the period 2009 through 2018. The report profiles 75 companies including many key and niche players such as ... \| read more...	$4,950.00
Plunkett's Biotech and Genetics Industry Almanac 2014: Biotech and Genetics Industry Market Research, Statistics, Trends and Leading Companies 9/26/2013 \| published by: Plunkett Research, Ltd. ... companies Industry Glossary Buyer may register for free access to search and export data at Plunkett Research Online Link to our 5-minute video overview of this industry Pages: 592 Statistical Tables Provided: 16 Companies Profiled: ... \| read more...	$349.99
Plunkett's Biotech and Genetics Industry Trends and Statistics 2014: A Summary Version of Plunkett's Biotech and Genetics Industry Almanac 2014 9/26/2013 \| published by: Plunkett Research, Ltd. ... 72 Statistical Tables Provided: 16 Geographic Focus: Global A condensed market research report excerpted from Plunkett’s Biotech & Genetics Industry Almanac 2014, including forecasts and market estimates, technologies analysis and vital statistical tables. You will ... \| read more...	$199.99
Nerve Repair and Regeneration Market by Xenografts (Conduits, Protectors), Neuromodulation [Internal (Spinal Cord, Deep Brain)], External (Transcranial Magnetic)], Surgery [Direct Nerve Repair, Grafting, Stem Cell] - Global Trend and Forecast to 2018 9/9/2013 \| published by: MarketsandMarkets ... repair and regeneration market was worth $4.1 billion in 2012 and is expected to grow at a CAGR of 11.5% in the next five years, primarily due to technological advancements and favorable reimbursement policies. The ... \| read more...	$4,650.00
Hematopoietic Stem Cell Transplantation - Pipeline Review, H2 2013 8/30/2013 \| published by: Global Markets Direct ... of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Hematopoietic Stem Cell Transplantation, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players ... \| read more...	$2,000.00
Cancer Stem Cells Drug Pipeline Update 2013 8/20/2013 \| published by: BioSeeker Group AB ... development and cancer drugs which are inhibitors of the Hedgehog, Notch, and WNT Pathway. These developmental pathways are frequently activated in neoplasms, and particularly in the rare subpopulation of cancer stem cells. There are today ... \| read more...	$3,747.50
Global Stem Cell Anticancer Therapeutics Market 2012-2016 8/16/2013 \| published by: Infiniti Research Limited - TechNavio ... of the key factors contributing to this market growth. The Global Stem Anticancer Therapeutics market has also been witnessing an increasing number of strategic alliances among vendors. However, stringent regulatory approval processes could pose a ... \| read more...	$2,000.00
The Market for Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) 8/15/2013 \| published by: Kalorama Information ... forming new tumors. These cells that leave the primary tumor are able to colonize distant organs in the body and initiate the process of metastasis; however, their biology is still not entirely elucidated. Circulating tumor ... \| read more...	$3,995.00
Stem Cell Technologies: World Market Outlook 2013-2023 8/2/2013 \| published by: Visiongain ... 2023. There you find the best places for sales growth, also understanding trends, technologies, therapies, and opportunities. That study gives you revenue forecasts to 2023 for the overall world market and its submarkets. See what's ... \| read more...	$2,633.00
Stem Cell Markets 8/1/2013 \| published by: TriMark Publications ... have been classified as either embryonic, adult (tissue-specific or cord blood) stem cells. Recent understanding of stem cell biology may provide new approaches for the treatment of a number of diseases as well as tissue/organ ... \| read more...	$3,400.00
Regenerative Medicine and Stem cells Partnering Terms and Agreements 8/1/2013 \| published by: Current Partnering ... companies. Trends in regenerative medicine and stem cells deals Deal terms analysis Partnering agreement structure Partnering contract documents Top deals by value Most active dealmakers Average deal terms for regenerative medicine and stem cells The ... \| read more...	$2,795.00
U.S Orthopedic Biomaterials Market 8/1/2013 \| published by: iData Research, Inc. ... new areas and medical devices. There is still tremendous potential for growth, especially in the younger market segments such as stem cells and concentration systems. Conversely, some products that previously experienced rapid market growth have ... \| read more...	$6,995.00
The 2013-2018 Outlook for Stem Cell Products in the United States 7/17/2013 \| published by: Icon Group International, Inc. ... (in millions of U.S. dollars), or potential industry earnings (P.I.E.) estimates are given across some 12,700 cities in the United States. For each city in question, the percent share the city is of it’s state ... \| read more...	$495.00
The 2013-2018 World Outlook for Stem Cell Products 7/15/2013 \| published by: Icon Group International, Inc. ... demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region and of the globe. These comparative benchmarks allow the reader ... \| read more...	$795.00
Regenerative Medicines: Bone and Joint Applications 6/1/2013 \| published by: BCC Research ... tissue damaged by injury, disease, or the aging process. Analyses of market trends, with data from 2012, estimates for 2013, and projections of compound annual growth rates (CAGRs) through 2018. Coverage of other regenerative applications, ... \| read more...	$5,450.00
Complete 2012-13 Induced Pluripotent Stem Cell Industry Report 6/1/2013 \| published by: BioInformant Worldwide, L.L.C. ... them to differentiate into a wide variety of specialized cell types. The possibilities arising from these characteristics has caused great commercial interest, with potential applications ranging from the use of stem cells in reversal or ... \| read more...	$3,495.00
Mesenchymal Stem Cells - Advances and Applications 6/1/2013 \| published by: BioInformant Worldwide, L.L.C. ... intense therapeutic interest because they represent a population of cells with the potential to treat a wide range of acute and degenerative diseases. MSCs are advantageous over other stem cells types for a variety of ... \| read more...	$3,495.00
Global Gene Therapy Market Analysis 6/1/2013 \| published by: RNCOS ... the most sought after research objectives for ‘difficult to cure’ diseases. The gene therapy market in spite of presenting few marketable products and being nascent in terms of revenue generation holds tremendous growth potential. As ... \| read more...	$1,200.00
Cell Therapy in the US - Industry Market Research Report 5/24/2013 \| published by: IBISWorld ... the five years to 2018, but it will still outpace a majority of the economy. This industry engineers human tissue, also known as cell therapy or regenerative medicine. Tissue engineering is the use of a ... \| read more...	$1,020.00
Blood: The Worldwide Market for Blood Products, Blood Testing, Blood Equipment, and Synthetic Blood Products 5/23/2013 \| published by: Kalorama Information ... as a result of aging populations in the U.S., Europe and Japan; ongoing technology advancements/new product introductions and indications; expansion of health coverage in the U.S. via health care reform; and continued strong promotion of ... \| read more...	$3,500.00

< prev 1 2 3 4 5 next >